elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28076123-38EB4110-DE7C-4530-B332-DF18BD099A30
Q28076123-38EB4110-DE7C-4530-B332-DF18BD099A30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076123-38EB4110-DE7C-4530-B332-DF18BD099A30
The cell cycle as a brake for β-cell regeneration from embryonic stem cells
P2860
Q28076123-38EB4110-DE7C-4530-B332-DF18BD099A30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076123-38EB4110-DE7C-4530-B332-DF18BD099A30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6601b8b11069ee43fb39e51511ce0e23d3886d41
P2860
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.